Skip to main content

Table 4 Overall LVEF of all patients pre-procedure compared with final follow-up (average 12 months ± 5.5 months) showing significant improvement

From: Safety and outcomes analysis: transcatheter implantation of autologous angiogenic cell precursors for the treatment of cardiomyopathy

Variable

n

Mean LVEF

SD

95% conf. interval

Pre-treatment

35

29.8

10.0

26.3–33.2

12-month follow-up

35

37.4

12.9

33.0–41.9

Difference

35

7.7

11.2

− 11.5–3.9

t = − 4.08

    

P < 0.003

    
  1. Paired t-test
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512